Dr. Simon Ducharme has a medical degree from the Université de Montréal and a Masters from McGill University. He completed his residency in Psychiatry at McGill in 2012, and a fellowship in Behavioral Neurology & Neuropsychiatry at Harvard University in 2014. He has a board certification in Behavioral Neurology & Neuropsychiatry from the United Council for Neurological Subspecialties. He currently works as a Neuropsychiatrist at the Montreal Neurological Institute and a C-L psychiatrist at the MUHC. His clinical interests are frontotemporal dementia and the neuropsychiatric aspects of epilepsy. Dr. Ducharme has received over 35 awards of academic or research excellence, including the 2013 Career Development Award from the American Neuropsychiatric Association. He currently holds an FRQS Junior 1 Clinician-Scientist award. His research uses advanced structural brain imaging techniques to study the longitudinal changes in brain development from childhood to old age, and how it impacts behavior across health and psychopathology. His current projects aim to develop novel neuroimaging diagnostic and prognostic biomarkers for frontotemporal dementia. He is the co-chair of the American Neuropsychiatric Association committee on research and also an associate member of the McGill Centre for Studies in Aging. Dr. Ducharme is also in charge of several clinical trials in Alzheimer’s disease and related dementia at the MNI.